The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Open accessAbstract
In order to adapt to the reduced availability of nutrients and oxygen in the tumor microenvironment and the increased requirements of energy and building blocks necessary for maintaining their high proliferation rate, malignant cells undergo metabolic changes that result in an increased production of lactate, nitric oxide, reactive oxygen species, prostaglandins and other byproducts of arachidonic acid metabolism that influence both the composition of the inflammatory microenvironment and the function of the tumor-associated macrophages (TAMs). In response to cues present in the TME, among which products of altered tumor cell metabolism, TAMs are also required to reprogram their metabolism, with activation of glycolysis, fatty acid synthesis and altered nitrogen cycle metabolism. These changes result in functional reprogramming of TAMs which includes changes in the production of cytokines and angiogenetic factors, and contribute to the tumor progression and metastasis. Understanding the metabolic changes governing the intricate relationship between the tumor cells and the TAMs represents an essential step towards developing novel therapeutic approaches targeting the metabolic reprogramming of the immune cells to potentiate their tumoricidal potential and to circumvent therapy resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“The tumor cell metabolism is therefore characterized by an increased glucose consumption, reflected by the upregulation of the glucose transporter (GLUT1) at the surface of the tumor cells, their increased glucose uptake and oxygen consumption [20,21].”
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 1×
“During the last decades, it has become clear that in many tumors a proinflammatory TME promotes cancer development, progression and metastasis[2; 3; 4; 5].”
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384 · cited 1×
“They are characterized by a high functional plasticity [12,13].”
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Jha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
The pentose phosphate pathway and cancer
Patra, K. C., & Hay, N. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.06.005 · Cited by 1,432
Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport
Fernie, A. R., Carrari, F., & Sweetlove, L. J. (2004) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2004.03.007 · Cited by 1,403
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages
Rath, M., Müller, I., Kropf, P., Closs, E. I., & Munder, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00532 · Cited by 1,262
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Upon increased nutrient diversion to the TCA cycle, intermediates of the TCA such as citrate can also be used for production of lipids and amino acids [27,29].”
M1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,141
A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidation
Houten, S. M., & Wanders, R. J. A. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9061-2 · Cited by 1,020
Clementi, E., Brown, G. C., Feelisch, M., & Moncada, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7631 · Cited by 863 · cited 1×
“The produced NO subsequently suppresses OXPHOS through the inhibition of enzymes involved in the TCA and electron transport chain and upregulates glycolysis [74,75].”
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4174 · Cited by 755
Van Dyken, S. J., & Locksley, R. M. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095906 · Cited by 714
Biswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Van Ginderachter, J. A., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 629
Induction of myeloid‐derived suppressor cells by tumor exosomes
Xiang, X., Poliakov, A., Liu, C., Liu, Y., Deng, Z., Wang, J., Cheng, Z., Shah, S. V., Wang, G., Zhang, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24249 · Cited by 598
Orchestration of Metabolism by Macrophages
Biswas, S. K., & Mantovani, A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.013 · Cited by 586 · cited 1×
“These changes shape on the one hand its cellular content through the release of various recruitment factors resulting in accumulation of specific types of immune cells into the TME, and on the other hand influence the function of these immune cells and the complex relationship between these cells and the tumor cells […”
Modolell, M., Corraliza, I. M., Link, F., Soler, G., & Eichmann, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250436 · Cited by 554
The impact of hypoxia on tumor-associated macrophages
Henze, A.-T., & Mazzone, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84427 · Cited by 546
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Wenes, M., Shang, M., Di Matteo, M., Goveia, J., Martín-Pérez, R., Serneels, J., Prenen, H., Ghesquière, B., Carmeliet, P., & Mazzone, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.008 · Cited by 496
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 462
Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal
Mills, E. L., & O'Neill, L. A. (2016) · European Journal of Immunology · doi:10.1002/eji.201445427 · Cited by 458
Nutrition, inflammation and cancer
Zitvogel, L., Pietrocola, F., & Kroemer, G. (2017) · Nature Immunology · doi:10.1038/ni.3754 · Cited by 446 · cited 1×
“Conversely, ketogenic diets that result in reduced lactate production could lead to a reduced lactate-mediated immunosuppression in the tumor microenvironment and improved anti-tumoral immune responses [87; 88].”
Ryder, M., Ghossein, R. A., Ricarte-Filho, J. C. M., Knauf, J. A., & Fagin, J. A. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0036 · Cited by 443
Macrophage polarization and plasticity in health and disease
Biswas, S. K., Chittezhath, M., Shalova, I. N., & Lim, J.-Y. (2012) · Immunologic Research · doi:10.1007/s12026-012-8291-9 · Cited by 394
Kunkel, M., Reichert, T. E., Benz, P., Lehr, H., Jeong, J., Wieand, S., Bartenstein, P., Wagner, W., & Whiteside, T. L. (2003) · Cancer · doi:10.1002/cncr.11159 · Cited by 390
Heusinkveld, M., de Vos van Steenwijk, P. J., Goedemans, R., Ramwadhdoebe, T. H., Gorter, A., Welters, M. J. P., van Hall, T., & van der Burg, S. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100889 · Cited by 368
Glycolysis in cancer: A potential target for therapy
Gatenby, R. A., & Gillies, R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.021 · Cited by 304
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
Laoui, D., Movahedi, K., Van Overmeire, E., Van den Bossche, J., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., De Baetselier, P., & Van Ginderachter, J. A. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113371dl · Cited by 304
Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Ueda, S.-I., Kimura, Y. N., Hamano, S., Sonoda, K.-H., Saijo, Y., Nukiwa, T., Strieter, R. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23298 · Cited by 286
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Asgharzadeh, S., Salo, J. A., Ji, L., Oberthuer, A., Fischer, M., Berthold, F., Hadjidaniel, M., Liu, C. W.-Y., Metelitsa, L. S., Pique-Regi, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.9169 · Cited by 285
Penny, H. L., Sieow, J. L., Adriani, G., Yeap, W. H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S. Y., Ho, Y. S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1191731 · Cited by 254
Daurkin, I., Eruslanov, E., Stoffs, T., Perrin, G. Q., Algood, C., Gilbert, S. M., Rosser, C. J., Su, L.-M., Vieweg, J., & Kusmartsev, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1261 · Cited by 235
Dinapoli, M. R., Calderon, C. L., & Lopez, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1323 · Cited by 204
Klimp, A. H., Hollema, H., Kempinga, C., van der Zee, A. G. J., de Vries, E. G. E., & Daemen, T. (2001) · PubMed · Cited by 199
Nonomura, N., Takayama, H., Nakayama, M., Nakai, Y., Kawashima, A., Mukai, M., Nagahara, A., Aozasa, K., & Tsujimura, A. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.09804.x · Cited by 197
Dwarakanath, B., Singh, D., Banerji, A., Sarin, R., Venkataramana, N., Jalali, R., Vishwanath, P., Mohanti, B., Tripathi, R., Kalia, V., et al. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.55136 · Cited by 194
Caillou, B., Talbot, M., Weyemi, U., Pioche-Durieu, C., Al Ghuzlan, A., Bidart, J. M., Chouaib, S., Schlumberger, M., & Dupuy, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022567 · Cited by 191
Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling
Chiang, C.-F., Chao, T.-T., Su, Y.-F., Hsu, C.-C., Chien, C.-Y., Chiu, K.-C., Shiah, S.-G., Lee, C.-H., Liu, S.-Y., & Shieh, Y.-S. (2017) · Oncotarget · doi:10.18632/oncotarget.14982 · Cited by 188
Van Overmeire, E., Laoui, D., Keirsse, J., Van Ginderachter, J. A., & Sarukhan, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00127 · Cited by 180
Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation
Grassian, A. R., Metallo, C. M., Coloff, J. L., Stephanopoulos, G., & Brugge, J. S. (2011) · Genes & Development · doi:10.1101/gad.16771811 · Cited by 180
Hassanzadeh Ghassabeh, G., De Baetselier, P., Brys, L., Noël, W., Van Ginderachter, J. A., Meerschaut, S., Beschin, A., Brombacher, F., & Raes, G. (2006) · Blood · doi:10.1182/blood-2005-04-1485 · Cited by 177
Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy
Barar, J., & Omidi, Y. (2013) · PubMed · doi:10.5681/bi.2013.036 · Cited by 175
Pinheiro, C. M., Sousa, B., Albergaria, A., Paredes, J., Dufloth, R. M., Vieira, D. S. C., Schmitt, F. C., & Baltazar, F. (2011) · PubMed · doi:10.14670/hh-26.1279 · Cited by 167
Gazi, E., Gardner, P., Lockyer, N. P., Hart, C. A., Brown, M. D., & Clarke, N. W. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700131-jlr200 · Cited by 166
Cunha, L. L., Morari, E. C., Guihen, A. C. T., Razolli, D., Gerhard, R., Nonogaki, S., Soares, F. A., Vassallo, J., & Ward, L. S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04482.x · Cited by 165
Ding, L., Liang, G., Yao, Z., Zhang, J., Liu, R., Chen, H., Zhou, Y., Wu, H., Yang, B., & He, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.5541 · Cited by 165
Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase
Sharda, D. R., Yu, S., Ray, M., Squadrito, M. L., Palma, M. D., Wynn, T. A., Morris, S. M., & Hankey, P. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003460 · Cited by 161
Emergence of spatial structure in the tumor microenvironment due to the Warburg effect
Carmona‐Fontaine, C., Bucci, V., Akkari, L., Déforet, M., Joyce, J. A., & Xavier, J. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311939110 · Cited by 147
Zhang, Y., Sun, Y., Rao, E., Yan, F., Li, Q., Zhang, Y., Silverstein, K. A. T., Liu, S., Sauter, E., Cleary, M. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2689 · Cited by 129
The Emerging “Hallmarks” of Metabolic Reprogramming and Immune Evasion: Distinct or Linked?
Kareva, I., & Hahnfeldt, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3696 · Cited by 124
Liu, D., Chang, C., Lü, N., Wang, X., Lu, Q., Ren, X., Ren, P., Zhao, D., Wang, L., Zhu, Y., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00604 · Cited by 123
Moore, G., & Pidgeon, G. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020236 · Cited by 120
Arts, R. J. W., Plantinga, T. S., Tuit, S., Ulas, T., Heinhuis, B., Tesselaar, M. H., Sloot, Y. J. E., Adema, G. J., Joosten, L. A. B., Smit, J. W. A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1229725 · Cited by 118
Self-citationTumour‐educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion
Karnevi, E., Andersson, R. E., & Rosendahl, A. H. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.22 · Cited by 106
Schumann, T., Adhikary, T., Wortmann, A., Finkernagel, F., Lieber, S., Schnitzer, E., Legrand, N., Schober, Y., Nockher, W. A., Toth, P. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3826 · Cited by 102
Wen, Z., Liu, H., Li, M., Li, B., Gao, W., Shao, Q., Fan, B., Zhao, F., Wang, Q., Xie, Q., et al. (2014) · Oncogene · doi:10.1038/onc.2014.85 · Cited by 102
Poczobutt, J. M., De, S., Yadav, V. K., Nguyen, T. T., Li, H. Y., Sippel, T. R., Weiser-Evans, M. C. M., & Nemenoff, R. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502364 · Cited by 101
Choi, J., Stradmann‐Bellinghausen, B., Yakubov, E., Savaskan, N. E., & Régnier‐Vigouroux, A. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1056406 · Cited by 95
Jiang, Q., Weiss, J. M., Back, T. C., Chan, T., Ortaldo, J. R., Guichard, S. M., & Wiltrout, R. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3968 · Cited by 86
Reyes, R., Wani, N. A., Ghoshal, K., Jacob, S. T., & Motiwala, T. (2016) · Gene Expression · doi:10.3727/105221616x693855 · Cited by 78
Modulation of glucose metabolism in macrophages by products of nitric oxide synthase
Albina, J. E., & Mastrofrancesco, B. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.6.c1594 · Cited by 75
Liu, Q., Li, Y., Niu, Z., Zong, Y., Wang, M., Yao, L., Lu, Z., Liao, Q., & Zhao, Y. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0304-4 · Cited by 63
Zhang, H., Wang, M.-D., Zhou, X., Qin, C., Fu, G., Tang, L., Wu, H., Huang, S., Zhao, L., Zeng, M., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.023 · Cited by 60
Wu, T., Sun, C., Chen, Z., Yu, Z., Peng, J., Qi, Z., Yang, X., & Zhao, Y. X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200068 · Cited by 56
Monjazeb, A. M., Zamora, A. E., Grossenbacher, S. K., Mirsoian, A., Sckisel, G. D., & Murphy, W. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00197 · Cited by 54
Hu, X., Liu, G., Hou, Y., Shi, J., Zhu, L., Jin, D., Peng, J., & Zhao, Y. X. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.47 · Cited by 47
Role of macrophage lipids in regulating tumoricidal activity
Schlager, S. I., Madden, L. D., Meltzer, M. S., Bara, S., & Mamula, M. J. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90006-0 · Cited by 46
Huang, C., Wang, S.-Y., Lin, L., Wang, P., Chen, T., Hsu, W., Lin, T., Liou, C., & Chuang, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021667 · Cited by 46
Wokoun, U., Hellriegel, M., Emons, G., & Gründker, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5491 · Cited by 45
WANG, Z., ZHANG, L., ZHANG, D., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2945 · Cited by 41
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2016) · Oncology Letters · doi:10.3892/ol.2016.5510 · Cited by 39
Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein
Rao, E., Singh, P., Zhai, X., Li, Y., Zhu, G., Zhang, Y., Hao, J., Chi, Y., Brown, R. E., Cleary, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3485 · Cited by 36
Sobhakumari, A., Orcutt, K. P., Love-Homan, L., Kowalski, C. E., Parsons, A. D., Knudson, C. M., & Simons, A. L. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14586627440192 · Cited by 29
Mustafa, E. H., Mahmoud, H. T., Alhudhud, M., Abdalla, M. Y., Ahmad, I. M., Yasin, S. R., Elkarmi, A., & Tahtamouni, L. H. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.8.3213 · Cited by 21
Cited by
Targeting Tumor Microenvironment for Cancer Therapy
Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Bader, J. E., Voss, K., & Rathmell, J. C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.034 · Cited by 1,030
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
Nakamura, K., & Smyth, M. J. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0306-1 · Cited by 516
Yang, E., Wang, X., Gong, Z., Yu, M., Wu, H., & Zhang, D. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00359-5 · Cited by 494
Metadata
- Authors
- Netea-Maier, R. T., Smit, J. W. A., & Netea, M. G.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 413
- Pages
- 102-109
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2765685996
- Cited by
- 326
- References
- 93
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.